Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F Scanlon

Showing results (181-190 of 198) with videos related to

Pageof 20
Sort By:
The Journal of Clinical Endocrinology and Metabolism|October 1, 1987
Free fatty acids block growth hormone (GH) releasing hormone-stimulated GH secretion in man directly at the pituitaryF F Casanueva, L Villanueva, C Dieguez, et al.
Clinical Endocrinology|April 1, 1979
Comparison of long-acting analogues of luteinizing hormone releasing hormone in manJ A Wass, G M Besser, A Gomez-Pan, et al.
The Journal of Clinical Endocrinology and Metabolism|May 3, 2003
Endothelial function and coagulant factors in growth hormone-treated hypopituitary adults receiving desmopressinJ C Smith, H A Lane, J Lewis, et al.
Clinical Endocrinology|April 1, 1986
The preoperative and postoperative investigation of TSH and prolactin release in the management of patients with hyperprolactinaemia due to prolactinomas and nonfunctional pituitary tumours: relationship to adenoma size at surgeryM F Scanlon, J R Peters, J Salvador, et al.
British Journal of Clinical Pharmacology|August 1, 1985
Anticonvulsant therapy and cortisol eliminationP J Evans, R F Walker, J R Peters, et al.
British Medical Journal (Clinical Research Ed.)|November 30, 1985
Management of selected patients with hyperprolactinaemia by partial hypophysectomyM F Scanlon, J R Peters, J P Thomas, et al.
Clinical Endocrinology|June 1, 1986
Growth hormone responses to GRF 1-29 in patients with primary hypothyroidism before and during replacement therapy with thyroxineR Valcavi, V Jordan, C Dieguez, et al.
British Journal of Clinical Pharmacology|January 1, 1977
Effects of nomifensine, an inhibitor of endogenous catecholamine re-uptake, in acromegaly, in hyperprolactinaemia, and against stimulated prolactin release in manM F Scanlon, A Gomez-Pan, B Mora, et al.
British Medical Journal (Clinical Research Ed.)|March 29, 1986
Trial of strategy for reducing the use of laboratory testsF G Fowkes, R Hall, J H Jones, et al.
Clinical Endocrinology|April 1, 1997
Treatment of macroprolactinoma with cabergoline: a study of 85 patientsC I Ferrari, R Abs, J S Bevan, et al.
Pageof 20

Showing results (181-190 of 198) with videos related to

Sort By:
Pageof 20
The Journal of Clinical Endocrinology and Metabolism|October 1, 1987
Free fatty acids block growth hormone (GH) releasing hormone-stimulated GH secretion in man directly at the pituitaryF F Casanueva, L Villanueva, C Dieguez, et al.
Clinical Endocrinology|April 1, 1979
Comparison of long-acting analogues of luteinizing hormone releasing hormone in manJ A Wass, G M Besser, A Gomez-Pan, et al.
The Journal of Clinical Endocrinology and Metabolism|May 3, 2003
Endothelial function and coagulant factors in growth hormone-treated hypopituitary adults receiving desmopressinJ C Smith, H A Lane, J Lewis, et al.
Clinical Endocrinology|April 1, 1986
The preoperative and postoperative investigation of TSH and prolactin release in the management of patients with hyperprolactinaemia due to prolactinomas and nonfunctional pituitary tumours: relationship to adenoma size at surgeryM F Scanlon, J R Peters, J Salvador, et al.
British Journal of Clinical Pharmacology|August 1, 1985
Anticonvulsant therapy and cortisol eliminationP J Evans, R F Walker, J R Peters, et al.
British Medical Journal (Clinical Research Ed.)|November 30, 1985
Management of selected patients with hyperprolactinaemia by partial hypophysectomyM F Scanlon, J R Peters, J P Thomas, et al.
Clinical Endocrinology|June 1, 1986
Growth hormone responses to GRF 1-29 in patients with primary hypothyroidism before and during replacement therapy with thyroxineR Valcavi, V Jordan, C Dieguez, et al.
British Journal of Clinical Pharmacology|January 1, 1977
Effects of nomifensine, an inhibitor of endogenous catecholamine re-uptake, in acromegaly, in hyperprolactinaemia, and against stimulated prolactin release in manM F Scanlon, A Gomez-Pan, B Mora, et al.
British Medical Journal (Clinical Research Ed.)|March 29, 1986
Trial of strategy for reducing the use of laboratory testsF G Fowkes, R Hall, J H Jones, et al.
Clinical Endocrinology|April 1, 1997
Treatment of macroprolactinoma with cabergoline: a study of 85 patientsC I Ferrari, R Abs, J S Bevan, et al.
Pageof 20